Forest Laboratories, Inc. (FRX) to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference
5/17/2013 7:34:55 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Forest Laboratories, Inc (NYSE: FRX) today announced that they will present data related to aclidinium bromide and roflumilast at the American Thoracic Society (ATS) International Conference on May 17-22 in Philadelphia, PA. Seven posters, two poster discussion sessions and one late breaking abstract will be presented for aclidinium bromide. Roflumilast related data will be highlighted in four posters and three poster discussion sessions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by